KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
73 hedge funds and large institutions have $226M invested in Kindred Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+10
Holders Change %
+15.87%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
30
Reduced
18
Closed
6
Calls
–
Puts
$352K
Net Calls
-$352K
Net Calls Change
+$132K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$10.4M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
$63.9M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
$23.6M |
| 4 |
Renaissance Technologies
New York
|
$10.1M |
| 5 |
BlackRock
New York
|
$14.1M |
